XNAS
HYPR
Market cap82mUSD
Oct 08, Last price
0.94USD
1D
10.73%
1Q
-13.75%
IPO
-89.77%
Name
Hyperfine Inc
Chart & performance
P/E
—
P/S
5.84
EPS
—
Div yield, %
—
Shrs. gr., 5y
30.18%
Rev. gr., 5y
115.18%
Revenues
14m
+5.22%
Net income
-36m
L-12.64%
CFO
-28m
L-27.91%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
HealthCor Catalio Acquisition Corp. currently has no substantial active business operations. Its primary objective is to complete a strategic business combination, such as a merger, share exchange, asset purchase, stock acquisition, corporate reorganization, or a similar deal, with one or more target entities. This company was formed in 2020 and is based in New York, New York.
Key people
Independent Chairman of the Board · since 2025
Thomas Teisseyre
Chief Operating Officer · since 2023
Brett Hale
Chief Financial Officer, Chief Administrative Officer, Chief Compliance Officer, Treasurer, Corporate Secretary · since 2023
Executive Chairman of the Board · since 2021
Director · since 2023
President, Chief Executive Officer, Director · since 2022
Independent Director · since 2021
Independent Director · since 2021
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||